General Information of the Cell Line
Cell Line ID
CL000091
Cell Line Name
MV4-11
Synonyms
MV-4-11
MV-4:11
MV4:11
MV 4;11
MV4;11
MV411
MV(4;11)
MV4II
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0064
Tissue Information
Peripheral blood
Disease
Childhood acute monocytic leukemia (NCIt: C9163)
Acute monoblastic/monocytic leukemia (ORDO: Orphanet_514)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01301, Bcl2-associated agonist of cell death
Compound ID Compound Name Compound Formula
CP0016361
N-(2-chlorophenyl)-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C20H13ClN6
 1
1
EC50 = 30 nM
   TI
   LI
   LO
   TS
CP0241639
N-[2-chloro-4-(4-methylpiperazin-1-yl)phenyl]-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C25H23ClN8
 1
1
EC50 = 30 nM
   TI
   LI
   LO
   TS
CP0210320
N-[2-fluoro-4-(2-pyrrolidin-1-ylethoxy)phenyl]-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C26H24FN7O
 1
1
EC50 = 40 nM
   TI
   LI
   LO
   TS
CP0069769
N-[2-chloro-4-(2-morpholin-4-ylethoxy)phenyl]-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C26H24ClN7O2
 1
1
EC50 = 50 nM
   TI
   LI
   LO
   TS
CP0152361
3-chloro-4-[[7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-yl]amino]phenol
   Show/Hide
C20H13ClN6O
 1
1
EC50 = 90 nM
   TI
   LI
   LO
   TS
CP0060127
5-(2-chloro-3-methoxyanilino)-N-methylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C21H17ClN4O2
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0204622
5-(2,6-difluoroanilino)benzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C19H12F2N4O
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0083301
N-(2-fluorophenyl)-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C20H13FN6
 1
1
EC50 = 140 nM
   TI
   LI
   LO
   TS
CP0060146
5-(2-fluoroanilino)-N-methylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C20H15FN4O
 1
1
EC50 = 200 nM
   TI
   LI
   LO
   TS
CP0075279
5-(2-chloroanilino)-N-ethylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C21H17ClN4O
 1
1
EC50 = 210 nM
   TI
   LI
   LO
   TS
CP0083291
N-(2,6-difluorophenyl)-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C20H12F2N6
 1
1
EC50 = 530 nM
   TI
   LI
   LO
   TS
CP0036258
5-(2,6-difluoroanilino)-N-methylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C20H14F2N4O
 1
1
EC50 = 760 nM
   TI
   LI
   LO
   TS
CP0036255
5-(2-chloroanilino)-N-propan-2-ylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C22H19ClN4O
 1
1
EC50 = 890 nM
   TI
   LI
   LO
   TS
CP0210095
5-(2-chloroanilino)-N-(2-methylpropyl)benzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C23H21ClN4O
 1
1
EC50 = 980 nM
   TI
   LI
   LO
   TS
CP0036253
5-(2-chloroanilino)-N-methylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C20H15ClN4O
 1
1
EC50 = 1020 nM
   TI
   LI
   LO
   TS
CP0060138
N-(2-chloro-3-methoxyphenyl)-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C21H15ClN6O
 1
1
EC50 = 1580 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0002211
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
   Show/Hide
C22H27FN4O2  2
1
IC50 = 4.3 nM
   TI
   LI
   LO
   TS
2
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0003676
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
   Show/Hide
C23H24N8O4S  1
1
IC50 = 0.43 nM
   TI
   LI
   LO
   TS
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3  1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0005166
BMS-354825
   Show/Hide
C22H26ClN7O2S  1
1
GI50 = 3600 nM
   TI
   LI
   LO
   TS
CP0007326
methyl 2-[[2-[(6-methoxy-1H-benzimidazol-2-yl)sulfanyl]acetyl]amino]benzoate
   Show/Hide
C18H17N3O4S  2
1
EC50 = 6530 nM
   TI
   LI
   LO
   TS
2
EC50 = 80740 nM
   TI
   LI
   LO
   TS
CP0007430
IBRUTINIB
   Show/Hide
C25H24N6O2  1
1
GI50 = 250 nM
   TI
   LI
   LO
   TS
CP0007710
2-[[1-[2-fluoro-4-[[5-methyl-4-(1-propan-2-ylpyrazol-4-yl)pyrimidin-2-yl]amino]phenyl]piperidin-4-yl]-methylamino]ethanol
   Show/Hide
C25H34FN7O  1
1
IC50 = 5.3 nM
   TI
   LI
   LO
   TS
CP0008108
(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol
   Show/Hide
C17H18N4O4  1
1
IC50 = 16 nM
   TI
   LI
   LO
   TS
CP0016361
N-(2-chlorophenyl)-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C20H13ClN6  1
1
EC50 < 30 nM
   TI
   LI
   LO
   TS
CP0016614
(2R)-N-[5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl]pyrrolidine-2-carboxamide;hydrochloride
   Show/Hide
C20H22ClFN4O2  1
1
IC50 = 24.8 nM
   TI
   LI
   LO
   TS
CP0016677
N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
   Show/Hide
C35H30N4O4  1
1
GI50 = 38 nM
   TI
   LI
   LO
   TS
CP0018477
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
   Show/Hide
C21H16ClF3N4O3  2
1
GI50 = 30 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.87 nM
   TI
   LI
   LO
   TS
CP0019438
8-[3-(1-benzothiophen-2-yl)-5-chloropyridin-4-yl]-2,8-diazaspiro[4.5]decan-1-one
   Show/Hide
C21H20ClN3OS  1
1
GI50 = 580 nM
   TI
   LI
   LO
   TS
CP0022230
N-cyclopentyl-4-methyl-5-[2-[(5-morpholin-4-ylpyridin-2-yl)amino]pyrimidin-4-yl]-1,3-thiazol-2-amine
   Show/Hide
C22H27N7OS  1
1
GI50 = 209 nM
   TI
   LI
   LO
   TS
CP0024991
LY2606368
   Show/Hide
C18H19N7O2  1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
CP0030740
1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morpholin-4-Yl)ethoxy]imidazo[2,1-B][1,3]benzothiazol-2-Yl}phenyl)urea
   Show/Hide
C29H32N6O4S  1
1
IC50 = 0.56 nM
   TI
   LI
   LO
   TS
CP0030986
N-(4-(2-propylhydrazine-1- carbonyl)benzyl)cinnamamide
   Show/Hide
C20H23N3O2  1
1
EC50 = 36.37 nM
   TI
   LI
   LO
   TS
CP0031589
Gilteritinib
   Show/Hide
C29H44N8O3  1
1
GI50 = 0.9 nM
   TI
   LI
   LO
   TS
CP0034613
N-[(2S,3R,4R,6R,18S)-18-hydroxy-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
   Show/Hide
C35H30N4O5  1
1
IC50 = 64 nM
   TI
   LI
   LO
   TS
CP0034962
16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one
   Show/Hide
C26H21N3O4  1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0036253
5-(2-chloroanilino)-N-methylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C20H15ClN4O  1
1
EC50 < 30 nM
   TI
   LI
   LO
   TS
CP0036255
5-(2-chloroanilino)-N-propan-2-ylbenzo[c][2,6]naphthyridine-7-carboxamide
   Show/Hide
C22H19ClN4O  1
1
EC50 = 224 nM
   TI
   LI
   LO
   TS
CP0037049
3-N-[4-(4-morpholin-4-ylcyclohexyl)phenyl]-1-pyridin-2-yl-1,2,4-triazole-3,5-diamine
   Show/Hide
C23H29N7O  1
1
IC50 = 0.2 nM
   TI
   LI
   LO
   TS
CP0044060
4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
   Show/Hide
C28H39N7O3  1
1
GI50 = 15.2 nM
   TI
   LI
   LO
   TS
CP0060138
N-(2-chloro-3-methoxyphenyl)-7-(1H-1,2,4-triazol-5-yl)benzo[c][2,6]naphthyridin-5-amine
   Show/Hide
C21H15ClN6O  1
1
EC50 = 93 nM
   TI
   LI
   LO
   TS
CP0065873
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2-(dimethylamino)ethanone
   Show/Hide
C26H29N7O2  1
1
GI50 = 22 nM
   TI
   LI
   LO
   TS
CP0093774
CHEMBL3414626
   Show/Hide
C30H42N8O3  1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
CP0126272
2-[[2-chloro-3-(2-methylpyridin-3-yl)-1-benzothiophen-5-yl]carbamoylamino]-N-[3-[methyl-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]amino]propyl]acetamide
   Show/Hide
C32H36ClN9O2S  1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0133576
GSK778
   Show/Hide
C30H33N5O3  1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0134906
4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-cyclopentyloxy-N-(1-methylpiperidin-4-yl)benzamide
   Show/Hide
C32H45N7O3  1
1
GI50 = 240 nM
   TI
   LI
   LO
   TS
CP0139017
2-[10-(2-methoxyethyl)-13-oxa-3,4,6,7,10-pentazatricyclo[7.4.0.02,6]trideca-1(9),2,4,7-tetraen-5-yl]-N-(piperidin-4-ylmethyl)quinolin-8-amine
   Show/Hide
C25H30N8O2  1
1
GI50 = 6460 nM
   TI
   LI
   LO
   TS
CP0161675
1-[4-[4-amino-3-[4-(2-morpholin-4-ylethoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea
   Show/Hide
C31H35N9O4  1
1
GI50 < 0.3 nM
   TI
   LI
   LO
   TS
CP0201392
4-[[(7R)-8-cyclopentyl-5,7-diethyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
   Show/Hide
C29H41N7O3  1
1
GI50 = 392 nM
   TI
   LI
   LO
   TS
CP0356954
2-[4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(3-phenylmorpholin-4-yl)quinazolin-2-yl]pyrazol-1-yl]ethanol
   Show/Hide
C28H28N6O3  1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0362727
N-[5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]-3-pyrrolidin-1-ylpropanamide
   Show/Hide
C21H23FN4O2  1
1
IC50 = 23.5 nM
   TI
   LI
   LO
   TS
CP0385350
N-[4-methyl-3-[1-(pyridine-4-carbonyl)piperidin-4-yl]oxyphenyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C26H24F3N3O3  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CP0388691
4-[[(7R)-5,7-dibenzyl-8-cyclopentyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
   Show/Hide
C39H45N7O3  1
1
GI50 = 1870 nM
   TI
   LI
   LO
   TS
CP0398548
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(3-morpholin-4-ylpropoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
   Show/Hide
C30H34N6O4S  1
1
IC50 = 0.79 nM
   TI
   LI
   LO
   TS
CP0404111
N-(4-bromophenyl)-2-(4-methylpiperazin-1-yl)-9-(oxan-2-yl)purin-6-amine
   Show/Hide
C21H26BrN7O  1
1
GI50 = 3204 nM
   TI
   LI
   LO
   TS
CP0404112
2-N-(4-aminocyclohexyl)-9-cyclopentyl-6-N-(4-pyrrolidin-1-ylphenyl)purine-2,6-diamine
   Show/Hide
C26H36N8  1
1
GI50 = 18 nM
   TI
   LI
   LO
   TS
CP0404149
(2R)-3-[[6-(4-bromoanilino)-9-cyclopentylpurin-2-yl]amino]-2-methylpropan-1-ol
   Show/Hide
C20H25BrN6O  1
1
GI50 = 1307 nM
   TI
   LI
   LO
   TS
CP0408774
2-N-(4-aminobutyl)-9-cyclopentyl-6-N-[4-(4-ethylpiperazin-1-yl)phenyl]purine-2,6-diamine
   Show/Hide
C26H39N9  1
1
GI50 = 12 nM
   TI
   LI
   LO
   TS
CP0427934
2-[[9-ethyl-2-(6-methoxypyridin-3-yl)-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]-N-hydroxypyrimidine-5-carboxamide
   Show/Hide
C24H28N10O4  1
1
IC50 = 8.85 nM
   TI
   LI
   LO
   TS
CP0435607
2-N-(4-aminocyclohexyl)-6-N-[4-(4-benzylpiperazin-1-yl)phenyl]-9-cyclopentylpurine-2,6-diamine
   Show/Hide
C33H43N9  1
1
GI50 = 17 nM
   TI
   LI
   LO
   TS
CP0451026
N-[(1R)-6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl]-2-(3-methoxy-4-methylphenyl)acetamide
   Show/Hide
C25H27N3O2  1
1
GI50 = 17200 nM
   TI
   LI
   LO
   TS
CP0455099
US10266535, Compound 47
   Show/Hide
C25H27N7O2  1
1
GI50 = 54 nM
   TI
   LI
   LO
   TS
CP0460455
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-[3-(4-methylsulfonylpiperazin-1-yl)propoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
   Show/Hide
C31H37N7O5S2  1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0469512
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-piperidin-1-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
   Show/Hide
C30H34N6O3S  1
1
IC50 = 0.88 nM
   TI
   LI
   LO
   TS
CP0469913
2-[[9-cyclopentyl-6-[4-(morpholin-4-ylmethyl)anilino]purin-2-yl]amino]ethanol
   Show/Hide
C23H31N7O2  1
1
GI50 = 110 nM
   TI
   LI
   LO
   TS
CP0472253
N-[(1R)-6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl]-3,5-dimethoxy-4-methylbenzamide
   Show/Hide
C25H27N3O3  1
1
GI50 = 7250 nM
   TI
   LI
   LO
   TS
CP0473492
US10266535, Compound 25
   Show/Hide
C28H33N7O2  1
1
GI50 = 120 nM
   TI
   LI
   LO
   TS
CP0473495
US10266535, Compound 33
   Show/Hide
C29H33N7O2  1
1
GI50 = 160 nM
   TI
   LI
   LO
   TS
CP0473574
2-[[2-(6-aminopyridin-3-yl)-9-methyl-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]-N-hydroxypyrimidine-5-carboxamide
   Show/Hide
C22H25N11O3  1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
CP0476440
1-[[5,6-dimethyl-2-(1H-pyrrol-2-yl)thieno[2,3-d]pyrimidin-4-yl]amino]-3-methylpyrrole-2,5-dione
   Show/Hide
C17H15N5O2S  1
1
GI50 = 452 nM
   TI
   LI
   LO
   TS
CP0482145
1-[[9-benzyl-6-(4-bromoanilino)purin-2-yl]amino]propan-2-ol
   Show/Hide
C21H21BrN6O  1
1
GI50 > 4000 nM
   TI
   LI
   LO
   TS
CP0487869
US10208056, Compound 43
   Show/Hide
C15H17N3O2  1
1
GI50 = 115 nM
   TI
   LI
   LO
   TS
CP0498453
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-(6-hydroxyimidazo[2,1-b][1,3]benzothiazol-2-yl)phenyl]urea
   Show/Hide
C23H21N5O3S  1
1
IC50 = 0.15 nM
   TI
   LI
   LO
   TS
CP0502995
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-[(4-ethylpiperazin-1-yl)methyl]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
   Show/Hide
C30H35N7O2S  1
1
IC50 = 0.38 nM
   TI
   LI
   LO
   TS
CP0505225
N-hydroxy-2-[methyl-[(9-methyl-6-morpholin-4-yl-2-pyridin-3-ylpurin-8-yl)methyl]amino]pyrimidine-5-carboxamide
   Show/Hide
C22H24N10O3  1
1
IC50 = 1.15 nM
   TI
   LI
   LO
   TS
CP0516564
US10266535, Compound 30
   Show/Hide
C23H24N6O3S  1
1
GI50 = 170 nM
   TI
   LI
   LO
   TS
CP0528739
5-[2-[1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]-4-[(3S)-3-phenylmorpholin-4-yl]quinazolin-6-yl]-1,3-dimethylpyridin-2-one
   Show/Hide
C32H34N6O3  1
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
CP0537114
4-[(4-fluorobenzoyl)amino]-N-hydroxybenzamide
   Show/Hide
C14H11FN2O3  1
1
IC50 = 3640 nM
   TI
   LI
   LO
   TS
CP0537556
N-(4-(2-propylhydrazine-1- carbonyl)benzyl)benzamide
   Show/Hide
C18H21N3O2  1
1
EC50 < 30 nM
   TI
   LI
   LO
   TS
CP0539833
5-[4-[(3S)-3-(4-fluorophenyl)morpholin-4-yl]-2-[1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]quinazolin-6-yl]-1,3-dimethylpyridin-2-one
   Show/Hide
C32H33FN6O3  1
1
IC50 = 290 nM
   TI
   LI
   LO
   TS
CP0540865
5-[[4-(methylamino)-5-(1-methylpyrazol-4-yl)pyrimidin-2-yl]amino]-3-[(3R)-piperidin-3-yl]oxypyridine-2-carbonitrile
   Show/Hide
C20H23N9O  1
1
IC50 = 39 nM
   TI
   LI
   LO
   TS
CP0547444
1-[4-[6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-[(2S)-4-methylsulfonyl-2-phenylpiperazin-1-yl]quinazolin-2-yl]pyrazol-1-yl]-2-methylpropan-2-ol
   Show/Hide
C31H35N7O4S  1
1
IC50 = 1130 nM
   TI
   LI
   LO
   TS
CP0552451
N-[(1R)-6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl]-2-methylpyridine-4-carboxamide
   Show/Hide
C22H22N4O  1
1
GI50 > 30000 nM
   TI
   LI
   LO
   TS
CP0558014
2-[[2-[4-(dimethylamino)phenyl]-9-methyl-6-morpholin-4-ylpurin-8-yl]methyl-methylamino]-N-hydroxypyrimidine-5-carboxamide
   Show/Hide
C25H30N10O3  1
1
IC50 = 0.89 nM
   TI
   LI
   LO
   TS
CP0573506
US10266535, Compound 27
   Show/Hide
C28H33N7O2  1
1
GI50 = 32 nM
   TI
   LI
   LO
   TS
CP0573507
US10266535, Compound 45
   Show/Hide
C27H31N7O2  1
1
GI50 = 27 nM
   TI
   LI
   LO
   TS
CP0699892
US9073922, 186
   Show/Hide
C22H24FN3O3  1
1
IC50 = 42 nM
   TI
   LI
   LO
   TS
CP0720691
6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine
   Show/Hide
C16H19Cl2N5  1
1
IC50 = 572 nM
   TI
   LI
   LO
   TS
CP0850545
1-(1-(Methylsulfonyl)piperidin-4-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C23H24N6O3S  1
1
GI50 = 630 nM
   TI
   LI
   LO
   TS
CP0882332
(3-((2-((7-Nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)benzamido)methyl)phenyl)boronic acid
   Show/Hide
C20H16BN5O6  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0890941
1-(4-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone
   Show/Hide
C26H29N7O2  1
1
GI50 = 110 nM
   TI
   LI
   LO
   TS
CP0927905
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-cyclopropylethanone
   Show/Hide
C27H28N6O2  1
1
GI50 = 410 nM
   TI
   LI
   LO
   TS
CP0927906
(R)-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)(cyclopropyl)methanone
   Show/Hide
C26H26N6O2  1
1
GI50 = 6500 nM
   TI
   LI
   LO
   TS
CP0943642
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]-pyrimidin-1-yl)pyrrolidin-1-yl)-2-(dimethylamino)ethanone
   Show/Hide
C25H27N7O2  1
1
GI50 = 83 nM
   TI
   LI
   LO
   TS
CP0943649
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)butan-1-one
   Show/Hide
C26H28N6O2  1
1
GI50 = 1200 nM
   TI
   LI
   LO
   TS
CP0955587
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethanone
   Show/Hide
C24H24N6O2  1
1
GI50 = 350 nM
   TI
   LI
   LO
   TS
CP0967545
(R)-3-(4-Phenoxyphenyl)-1-(1-(propylsulfonyl)piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C25H28N6O3S  1
1
GI50 = 760 nM
   TI
   LI
   LO
   TS
CP0967554
(R)-1-(1-(Ethylsulfonyl)piperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C24H26N6O3S  1
1
GI50 = 570 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6 Homo sapiens (Human) Adult acute monocytic leukemia
HL-60 Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-13 Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2 Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14 Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1 Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue Homo sapiens (Human) Childhood acute monocytic leukemia
SEM Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
Jurkat E6.1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-CEM Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
EoL-1 Homo sapiens (Human) Chronic eosinophilic leukemia, not otherwise specified
CII Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL Homo sapiens (Human) Erythroleukemia
UKE-1 Homo sapiens (Human) Essential thrombocythemia
L-1236 Homo sapiens (Human) Hodgkin lymphoma
Granta-519 Homo sapiens (Human) Mantle cell lymphoma
JeKo-1 Homo sapiens (Human) Mantle cell lymphoma
Mino Homo sapiens (Human) Mantle cell lymphoma
HMC-1 Homo sapiens (Human) Mast cell leukemia
NK-92 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
RPMI-8226 Homo sapiens (Human) Plasma cell myeloma
OPM-2 Homo sapiens (Human) Plasma cell myeloma
U266B1 Homo sapiens (Human) Plasma cell myeloma
KMS-18 Homo sapiens (Human) Plasma cell myeloma
MM1.S Homo sapiens (Human) Plasma cell myeloma
MM1.R Homo sapiens (Human) Plasma cell myeloma
OPM-1 Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40 Homo sapiens (Human) Plasma cell myeloma
HuT 78 Homo sapiens (Human) Sezary syndrome
H9 Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1 Homo sapiens (Human) Sickle cell disease
RBL-1 Rattus norvegicus (Rat) Rat leukemia
RBL-2H3 Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28 Homo sapiens (Human) -
JY Homo sapiens (Human) -
C.M.L. Homo sapiens (Human) -
BON Homo sapiens (Human) -
PBMC iPSC #1 Homo sapiens (Human) -
LCL 721 Homo sapiens (Human) -